Markets:

Overview

News

Currencies

International

Treasuries

Amgen (NQ:AMGN)

403.26 -4.57 (-1.12%)

Streaming Delayed Price Updated: 11:49 AM EDT, Aug 6, 2026 Add to My Watchlist

Quote

Overview Detailed Quote Charting Historical Prices

News

All News News Headlines Press Releases

Research

Quarterly Reports Insider Filings Other Filings

All News about Amgen

< Previous 1 2

...

27 28 29 30 31 32 33 34 35

...

69 70 Next >

What's Going On With CytomX Stock? ↗

May 01, 2024

CytomX Therapeutics shares are racing higher Wednesday. The company said it will report first-quarter results and provide an initial CX-904 Phase 1a dose escalation update on May 8, after the close of...

Via Benzinga

Sandoz Settles Patent Dispute With Amgen Related To Bone Disorder Drug Denosumab ↗

April 30, 2024

Sandoz resolves patent litigation with Amgen, paving the way for the launch of denosumab biosimilars Jubbonti and Wyost.

Via Benzinga

Topics Intellectual Property

Will Earnings Cheer Continue To Buoy Markets? Apple, Amazon, Pfizer, Coinbase Lead Flurry Of Q1 Reports This Week ↗

April 29, 2024

With the earnings season now halfway through, the percentage of S&P 500 companies reporting positive earnings surprises and the magnitude of earnings surprises were above their 10-year averages.

Via Benzinga

Topics Stocks

Why Is Cullinan Therapeutics Stock Trading Higher On Wednesday? ↗

April 24, 2024

Explore the use of Amgen's Blincyto in treating severe systemic sclerosis, shedding light on Cullinan Therapeutics' CLN-978 potential for autoimmune diseases, particularly systemic lupus...

Via Benzinga

Better Buy: Pfizer vs. Viking Therapeutics ↗

April 23, 2024

These two pharma stocks have followed distinct paths of late. Which is the better investment?

Via The Motley Fool

1 No-Brainer Vanguard Fund to Buy Right Now ↗

April 23, 2024

This Vanguard growth fund is home to some of the world's most innovative companies.

Via The Motley Fool

How Is The Market Feeling About Amgen? ↗

April 19, 2024

Via Benzinga

Looking At Amgen's Recent Unusual Options Activity ↗

April 12, 2024

Via Benzinga

The Dividend Goldmine: 3 Shining Stocks With Growing Payouts ↗

April 19, 2024

Explore opportunities in the cable, restaurant and biotechnology sectors, revealing how dividend growth stocks are maximizing returns.

Via InvestorPlace

Amgen/AstraZeneca's Asthma Drug Tezspire Vs. Sanofi/Regeneron's Blockbuster Dupixent - Analyst Gives His Pick ↗

April 17, 2024

Amgen's Tezspire shows promising COPD trial results and potential market expansion beyond asthma. Comparison with Dupixent reveals significant benefits for eosinophil counts ≥150 cells/μL and ≥300...

Via Benzinga

Visa To Rally Around 18%? Here Are 10 Top Analyst Forecasts For Wednesday ↗

April 17, 2024

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades and downgrades, please see our analyst ratings page.

Via Benzinga

Coming FDA Approvals Could Send These 3 Drug Stocks Soaring ↗

April 17, 2024

When it comes to drug stocks, FDA approval can bring years or even decades of steady, high-margin revenue.

Via InvestorPlace

Sell These 3 Blue-Chip Stocks Before the Next Earnings Stumble ↗

April 17, 2024

Though stocks that make the Dow 30 are often seen as solid investments, investors should consider these three blue chip stocks to sell.

Via InvestorPlace

Topics Stocks

Is Amgen Stock a Buy? ↗

April 11, 2024

Amgen's stock isn't expensive, but the business does face some challenges, which could have investors thinking twice.

Via The Motley Fool

7 Analysts Have This To Say About Amgen ↗

April 03, 2024

Via Benzinga

Amgen Unusual Options Activity For April 02 ↗

April 02, 2024

Via Benzinga

Can This High-Yield Dividend Stock Keep Beating the S&P 500? ↗

April 17, 2024

Amgen's shares have come under pressure this year, making it a compelling bargain buy.

Via The Motley Fool

Topics Stocks

Got $5,000? Here Are 3 Undervalued Stocks to Buy and Hold Forever ↗

April 17, 2024

Not every business in operation today is built to thrive -- or even last -- indefinitely. These are.

Via The Motley Fool

The 3 Best Biotech Stocks to Buy Now: Q2 Edition ↗

April 16, 2024

Investors can find some of the hottest, most explosive opportunities in these three top biotech stocks to buy now.

Via InvestorPlace

3 Stocks to Buy Low Today With High Hopes for Tomorrow ↗

April 15, 2024

Amgen, Canadian Solar, and Diana Shipping are three undervalued stocks with high potential for growth that can enhance portfolio returns.

Via InvestorPlace

Amgen, Shell And More On CNBC's 'Final Trades' ↗

April 15, 2024

On CNBC’s "Halftime Report Final Trades," Amy Raskin of Chevy Chase Trust said Shell plc (NYSE: SHEL) has 12% free

Via Benzinga

Election Year Encore: Can 2020’s Top 7 Stock Winners Repeat Their Performance in 2024? ↗

April 09, 2024

These seven companies were the top 2020 stocks. After their glory years have faded, they are looking to turn their fortunes around.

Via InvestorPlace

3 High-Growth Biotech Stocks Investors Shouldn’t Sleep On in April ↗

April 09, 2024

These high-growth biotech stocks are certainly worth considering for investors looking for market-beating returns in the long-term.

Via InvestorPlace

The 3 Most Undervalued S&P 500 Stocks to Buy in April 2024 ↗

April 07, 2024

Our economy is on the up and up, and investing is a must. Let's review the most undervalued S&P 500 stocks to buy in April.

Via InvestorPlace

Topics Economy Stocks

2 Biotech Stocks to Buy Hand Over Fist in April ↗

April 06, 2024

These drugmakers have made important moves over the past year.

Via The Motley Fool

3 Stocks to Consider Adding to Your Retirement Portfolio in April ↗

April 05, 2024

Use the recent short-term weakness from these powerhouse companies' stocks to your advantage.

Via The Motley Fool

Topics Retirement

Is Amgen The Rare Biotech With A Safe Dividend? ↗

April 03, 2024

Amgen pays a $2.25 per share quarterly dividend, which comes out to a 3.3% yield. Biotech can be notoriously volatile, though, so can investors count on receiving the same dividend quarter after...

Via Talk Markets

Biotech Sector Nears Breakout: Will it Outperform in Q2?

April 03, 2024

The Biotech sector ETF is consolidating in its upper range, indicating a potential sector breakout despite modest year-to-date gains

Via MarketBeat

Topics ETFs

5 Healthcare Stocks to Buy for 2024 ↗

April 02, 2024

Healthcare stocks have been some of the top performers in 2024, and thanks to the potential of AI, these names will just keep heating up.

Via InvestorPlace

Topics Artificial Intelligence

Redditors Identify 'Best Undervalued Stocks' For 2024 ↗

April 01, 2024

Savvy investors at Reddit discuss undervalued stocks for potential growth. Top picks include META, Google, Starbucks, Verizon, and others, with varied perspectives on their potential.

Via Benzinga

< Previous 1 2

...

27 28 29 30 31 32 33 34 35

...

69 70 Next >

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.